<DOC>
	<DOCNO>NCT02103855</DOCNO>
	<brief_summary>Kidney damage major complication current antirejection medicine use transplantation . An increase number brittle diabetic successfully receive pancreas transplant . One challenge follow pancreas transplant patient develop kidney damage one antirejection medicine , tacrolimus . The objective study substitute new antirejection medicine cause kidney damage , belatacept tacrolimus patient develop sign tacrolimus relate kidney damage slow progression kidney disease .</brief_summary>
	<brief_title>Switch From Calcineurin Inhibitor Belatacept Pancreas Transplant Recipients</brief_title>
	<detailed_description>Nephrotoxicity major complication current immunosuppression regimen use transplantation . Pancreas transplantation increasedly perform manage labile diabetes mellitus last decade survival rate pancreatic graft improve . One challenge face follow pancreas transplantation alone pathologic change diabetes frequently see native kidney pancreas transplant recipient . High level calcineurin inhibitor ( CNI ) identify risk factor decline kidney function progression end-stage renal disease . The objective trial take subject biopsy proven CNI toxicity CNI begin belatacept , CNI . The hypothesis switch pancreas transplant subject document CNI kidney toxicity belatacept slow progression chronic kidney disease .</detailed_description>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Pancreas transplant alone recipients EBV IgG positive Biopsy proven calcineurin inhibitor toxicity native kidney biopsy Maintained regimen tacrolimus , sirolimus , mycophenolate EBV IgG negative Not maintain immunosuppression regimen contain tacrolimus Unable unwilling give inform consent Active infection History malignancy post transplant Glomerular filtration rate &lt; 15 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>pancreas transplantation</keyword>
	<keyword>immunosuppression</keyword>
	<keyword>belatacept</keyword>
</DOC>